FDA Approved: ABACAVIR AND LAMIVUDINE — Supplemental Application (Cipla USA Inc.)

View source ↗

Summary

FDA approved a supplemental application from Cipla USA Inc. for abacavir and lamivudine (abacavir/lamivudine).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• ABACAVIR AND LAMIVUDINE (abacavir/lamivudine)

Snippet

SUPPL AP for ABACAVIR AND LAMIVUDINE (ABACAVIR AND LAMIVUDINE)